Expression of the cell cycle regulators p53, p21(WAF1/CIP1) and p16(INK4a) in human endometrial adenocarcinoma

To study correlation links between expression level of proteins p53, p21(WAF1/CIP), p16(INK4) and proliferative potential in human endometrial adenocarcinoma (EC). The immunohistochemical analysis of expression level of Ki-67, p53, p21(WAF1/CIP) and p16(INK4) was carried out on surgically resected e...

Full description

Saved in:
Bibliographic Details
Published inExperimental oncology Vol. 28; no. 2; p. 152
Main Authors Buchynska, L G, Nesina, I P
Format Journal Article
LanguageEnglish
Published Ukraine 01.06.2006
Subjects
Adenocarcinoma - diagnosis
Adenocarcinoma - pathology
Adult
Aged
Cell Proliferation
Cyclin-Dependent Kinase Inhibitor p16 - analysis
Cyclin-Dependent Kinase Inhibitor p21 - analysis
Endometrial Neoplasms - diagnosis
Endometrial Neoplasms - pathology
Female
Humans
Middle Aged
Prognosis
Tumor Suppressor Protein p53 - analysis
Online AccessGet more information

Cover

More Information
Summary:To study correlation links between expression level of proteins p53, p21(WAF1/CIP), p16(INK4) and proliferative potential in human endometrial adenocarcinoma (EC). The immunohistochemical analysis of expression level of Ki-67, p53, p21(WAF1/CIP) and p16(INK4) was carried out on surgically resected endometrial cancer samples (n = 74). Scrapes of normal endometrium from 10 patients with polyps of cervical canal of the uterus served as the control. The data showed that endometrial malignant tumors possess high proliferative activity (proliferation index was 37.3 +/- 0.2%), overexpression of p53 (labeling index (LI) = 46.1 +/- 0.5%) and high expression of p21(WAF1/CIP) (LI = 11.2 +/- 0.4%) and p16(INK4) (LI = 12.0 +/- 0.2%). In low differentiated endometrial adenocarcinomas the highest level of Ki-67, p53 and p21(WAF1/CIP) expression and lowest content of p16(INK4) protein were observed. The indicated markers may be used along with traditional morphological and clinical characteristics for diagnosis of endometrial neoplasia.
ISSN:1812-9269